Indegene IPO Details, Financials, Valuation & Peers
Get everything you need to know about the Indegene IPO. Explore Indegene IPO details, including IPO dates, financial statements, valuation, peer comparison, and more.
Overview
Indegene Limited is a leading provider of digital-led commercialization services for the life sciences industry. Established over two decades ago, the company specializes in assisting biopharmaceutical, emerging biotech, and medical devices companies with various aspects of their operations, from drug development and clinical trials to regulatory compliance and sales and marketing. Leveraging a combination of healthcare domain expertise and purpose-built technology, Indegene offers comprehensive solutions that enable clients to navigate the complexities of the industry in a more efficient, effective, and modern manner.
Key Points:
- Comprehensive Solutions: Indegene offers end-to-end solutions for life sciences companies, leveraging over two decades of expertise in healthcare and purpose-built technology. Their services span commercial, medical, regulatory, and R&D operations, providing holistic support to clients.
- Client Base: With established relationships with the top 20 biopharmaceutical companies globally, Indegene derives a significant portion of its revenue from these key clients. Additionally, they serve a diverse range of clients, totaling 65 active clients as of December 31, 2023.
- Indegene Limited offers comprehensive solutions including Enterprise Commercial, Omnichannel Activation, Enterprise Medical, and Enterprise Clinical Solutions, leveraging digital technologies and AI-powered tools to streamline operations and drive efficiency across the life sciences industry.
- Technological Expertise: Indegene specializes in converting unstructured clinical data into structured content and analytics-ready datasets. Their AI-powered solutions enhance cost efficiency, speed to market, and regulatory compliance, requiring minimal human intervention.
Objects of the Issue
- Repayment/prepayment of indebtedness of one of the Material Subsidiaries, ILSL Holdings, Inc.
- Funding the capital expenditure requirements of the Company and one of the Material Subsidiaries, Indegene, Inc.
- General corporate purposes and inorganic growth
IPO Details
Discover essential information crucial for understanding an IPO, including the Price Band, Fresh Issue, Offer For Sale, Total IPO Size and more. Explore these key details to gain insight into the company's public offering.
| Fields | Details |
|---|---|
| IPO Dates | 06 May - 08 May 2024 |
| IPO Price Band | ₹ 430 - 452 per share |
| Fresh Issue | Upto ₹ 760 crore |
| Offer For Sale | Up to 23,932,732 Shares (₹ 1,081.76 crore) |
| Total IPO Size | Approx ₹ 1841.76 crore |
| Face Value | ₹ 2 |
| Listing On | BSE, NSE |
IPO Timeline
Explore important dates like IPO opening, closing, listing and others, outlining the journey of the Public Offering. This will help you grasp the entire IPO journey effortlessly.
| Event | Date |
|---|---|
| IPO Opening Date | 06 May 2024 |
| IPO Closing Date | 08 May 2024 |
| Basis Of Allotment | 09 May 2024 |
| Refunds | 10 May 2024 |
| Demat Transfer | 10 May 2024 |
| IPO Listing Date | 13 May 2024 |
Financial Statements
Explore a comprehensive financial data table showcasing key metrics including revenue, expenses, net income, and others. Gain valuable insights about the company's financial performance at a glance, facilitating informed decision-making and strategic planning for subscribing to the IPO.
| Period Ended | 31st March 2021 | 31st March 2022 | 31st March 2023 | Dec 2023 |
|---|---|---|---|---|
| Total Income | 996.9 | 1,690.5 | 2,364.1 | 1,969.75 |
| Total Expenses | 786.2 | 1,417.1 | 2,001.05 | 1,644.6 |
| Net Profit/Loss | 185.68 | 162.82 | 266.1 | 241.9 |
| NPM (*) | 19.22 | 9.78 | 11.54 | 12.62 |
| Total Assets | 596.04 | 1,353.5 | 2,203.87 | 2,518.15 |
| Total Liabilities | 262.96 | 589.57 | 1,140.14 | 1,191.15 |
* NPM represents the net profit margin, calculated as a percentage. All other figures are presented in crore (₹cr)
Valuation
Uncover significant valuation metrics such as EPS (Earnings Per Share), ROE (Return on Equity), ROCE (Return on Capital Employed), D/E Ratio (Debt-to-Equity Ratio), Current Ratio, and EBITDA Margin. These key indicators offer insights into the company's financial standing and performance, aiding in informed investment decisions.
| Period Ended | 31st March 2021 | 31st March 2022 | 31st March 2023 | Dec 2023 |
|---|---|---|---|---|
| EPS | 7.01 | 7.46 | 11.97 | 10.84 |
| ROE (%) | 55.79 | 21.31 | 25.02 | 18.24 |
| ROCE (%) | NA | NA | NA | NA |
| D/E Ratio | 0.07 | 0.02 | 0.37 | 0.30 |
| Current Ratio | 2.30 | 2.56 | 2.96 | 2.75 |
| EBITDA MARGIN (%) | 27.03 | 18.79 | 19.69 | 21.91 |
* Compiled from DRHP/RHP for valuation purposes.
Peer Comparison
No listed peers available for comparison.
Subscription Data from NSE and BSE
| Investor Type | Subscribed |
|---|---|
| Qualified Institutional Buyer (QIB) | 192.72 |
| Non-Institutional Investor (NII) | 55.91 |
| Retail Individual Investor (RII) | 7.86 |
| Total | 70.3 |
* All figures represent multiples of the subscription. Check subscriptions for other ongoing issues here.
IPO Registrar
Link Intime India Private Ltd
Phone: + 91 810 811 4949
Email: ipo.helpdesk@linkintime.co.in
Website: https://linkintime.co.in/
Company Promoters
The company is managed professionally without a designated promoter, in accordance with SEBI ICDR Regulations and the Companies Act.
Lead Managers
- Kotak Mahindra Capital Company Limited
- Citigroup Global Markets India Private Limited
- J.P. Morgan India Private Limited
- Nomura Financial Advisory and Securities (India) Private Limited
Company Address
Indegene Limited
Aspen Block G4, 3 rd Floor, Manyata Embassy Business Park, Outer Ring Road, Nagawara, Bengaluru 560 045, Karnataka, India
Phone: +91 80 4674 4567/ +91 80 4644 7777
Email: compliance.officer@indegene.com
Website: www.indegene.com
FAQs
- What is the issue size of the Indegene Limited IPO?The Indegene Limited IPO has an issue size of Approx ₹ 1841.76 crore. This includes a fresh issue of Upto ₹ 760 crore and an offer for sale (OFS) of Up to 23,932,732 Shares (₹ 1,081.76 crore).
- What is the price band of the Indegene Limited IPO?The price band for the Indegene Limited IPO is ₹ 430 - 452 per share.
- What are the bidding dates for the Indegene Limited IPO?The Indegene Limited IPO will open for bidding on 06 May 2024 and close on 08 May 2024.
- What is the allotment date for the Indegene Limited IPO?The allotment date for the Indegene Limited IPO is 09 May 2024.
- What is the listing date for the Indegene Limited IPO?The listing date for the Indegene Limited IPO is 13 May 2024.
- What is the Indegene Limited IPO grey market premium?The grey market premium (GMP) for the Indegene Limited IPO is currently at ₹275, with an expected listing gain of approximately 60.84%. Remember, the grey market premium is not an official indicator, but it reflects market perception and demand for the IPO shares.